Venture Round - MyoKardia
Investment Firm
Overview
MyoKardia is a clinical-stage biopharmaceutical company that develops targeted therapies for the treatment of rare cardiovascular diseases.
Announced Date
Oct 04, 2012
Funding Type
Series Unknown
Highlights
Location
United States, North America
Social
Investor Lead
N/A
Participant Investors
1
No investment info available on this profile
Round Details and Background
MyoKardia raised $4000000 on 2012-10-04 in Venture Round
MyoKardia is a clinical-stage biopharmaceutical company that develops targeted therapies for the treatment of rare cardiovascular diseases.
Company Funding History
5
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Apr 30, 2015 |  Series B - MyoKardia | 5 | - | 46.0M |
| Aug 22, 2014 | Venture Round - MyoKardia | 6 | - | 10.0M |
| Oct 04, 2012 | Venture Round - MyoKardia | - | 4.0M | |
| Sep 20, 2012 | Series A - MyoKardia | 1 | - | 38.0M |
Recent Activity
There is no recent news or activity for this profile.